And whatever membership you choose, you can cancel at any time
Medical Writing Assistance Medical writing and editorial support were provided by Debbie Day of Axis, a division of Spirit Medical Communications Group Limited (funded by Novo Nordisk Inc.) under the direction of the authors
Werge MP, McCann A, Rashu EB, Lam SM, Hetland LE, Thing M, Nabilou P, Junker AE, Norlin J, Veidal S, Holst D, Bugge A, Viuff BM, Hvid H, Bendtsen KM, Mazzoni G, Harder LM, Vyberg M, Serizawa R, Bendtsen F, Ueland PM, Galsgaard ED, Wewer Albrechtsen NJ, Gluud LL
GLP-1 drugs also called GLP-1 agonists were originally developed to treat type 2 diabetes
This trial was stopped early because the benefits were so clear that continuing to give placebo was deemed unethical